Axogen, Inc. — Director's Dealing 2016

Oct 14, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AxoGen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2016-10-07

Reporting Person: Zaderej Karen L. (Director, CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-10-07	Common Stock	P	10000	$7.50	Acquired	242147	Direct

Footnotes

F1: The reporting person purchased these shares in her individual capacity and not through any directed share or other formal program in connection with an underwritten registered public offering of the Company. On October 7, 2016, the trade date for the public offering, the closing sale price reported by NASDAQ was $9.15 per share. The public offering closed on October 13, 2016 and the closing sale price reported by NASDAQ on such date was $8.72 per share.